{
  "id": 3606268,
  "title": "Is Wall Street Bullish or Bearish on Insulet Stock?",
  "url": "https://urgent.news/2026/08/25/is-wall-street-bullish-or-bearish-on-insulet-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-25T14:12:11.000Z",
  "source": {
    "name": "Yahoo Finance",
    "slug": "yahoo-finance",
    "url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-bullish-bearish-insulet-141211574.html"
  },
  "original_language": "en",
  "account": "Insulet Corporation (PODD), a medical device company specializing in insulin delivery systems for individuals with insulin-dependent diabetes, has been underwhelming in comparison to the broader market. Over the past year, PODD stock has declined by 56%, whereas the S&P 500 Index has surged nearly 18.3%. In 2026, PODD is projected to drop 48.8%, while the S&P 500 has grown by 11.8% year-to-date. Among 27 analysts covering PODD stock, the consensus stands at a Moderate Buy, with 13 Strong Buy ratings, two Moderate Buys, 11 Holds, and one Strong Sell. Citi analyst Joanne Wuensch has maintained a Hold rating on PODD, with a price target of $150, suggesting an 18.6% upside potential from its current level. Although PODD beat earnings expectations in the previous four quarters, its stock performance has been downgraded due to commercial friction in its Type 2 diabetes segment, adoption concerns, and intensifying competition.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}